TOFACITINIB

You have access
A Retrospective Analysis of Outcome in Melanoma Differentiation–Associated Gene 5–Related Interstitial Lung Disease Treated with Tofacitinib or Tacrolimus
Li Fan, Wenting Lyu, Huarui Liu, Hanyi Jiang, Lulu Chen, Yin Liu, Yi Zhuang, Mei Huang, Min Cao, Hourong Cai, Yonglong Xiao and Jinghong Dai

The Journal of Rheumatology December 1 2022, 49 (12) 1356-1364; DOI: https://doi.org/10.3899/jrheum.220367
You have access
Physician- and Patient-reported Effectiveness Are Similar for Tofacitinib and TNFi in Rheumatoid Arthritis: Data From a Rheumatoid Arthritis Registry
Mohammad Movahedi, Angela Cesta, Xiyuing Li, Edward C. Keystone, Claire Bombardier and the OBRI Investigators

The Journal of Rheumatology May 1 2022, 49 (5) 447-453; DOI: https://doi.org/10.3899/jrheum.211066
You have access
Treatment With Tofacitinib in Refractory Psoriatic Arthritis: A National Multicenter Study of the First 87 Patients in Clinical Practice
Eva Galíndez-Agirregoikoa, Diana Prieto-Peña, José Luis Martín-Varillas, Beatriz Joven, Olga Rusinovich, Rafael B. Melero-González, Francisco Ortiz-Sanjuan, Raquel Almodóvar, Juan José Alegre-Sancho, Ángels Martínez, Agustí Sellas-Fernández, Lara Méndez, Rosario García-Vicuña, Belén Atienza-Mateo, Iñigo Gorostiza, Miguel Ángel González-Gay and Ricardo Blanco on behalf of the Tofacitinib PsA Clinical Practice Collaborative Group

The Journal of Rheumatology October 1 2021, 48 (10) 1552-1558; DOI: https://doi.org/10.3899/jrheum.201204
Open Access
Radiographic Progression According to Baseline C-reactive Protein Levels and Other Risk Factors in Psoriatic Arthritis Treated with Tofacitinib or Adalimumab
Désirée van der Heijde, Dafna D. Gladman, Oliver FitzGerald, Arthur Kavanaugh, Daniela Graham, Cunshan Wang and Lara Fallon

The Journal of Rheumatology September 1 2019, 46 (9) 1089-1096; DOI: https://doi.org/10.3899/jrheum.180971
Open Access
Effect of Glucocorticoids on the Clinical and Radiographic Efficacy of Tofacitinib in Patients with Rheumatoid Arthritis: A Posthoc Analysis of Data from 6 Phase III Studies
Christina Charles-Schoeman, Désirée van der Heijde, Gerd R. Burmester, Peter Nash, Cristiano A.F. Zerbini, Carol A. Connell, Haiyun Fan, Kenneth Kwok, Eustratios Bananis and Roy Fleischmann

The Journal of Rheumatology February 1 2018, 45 (2) 177-187; DOI: https://doi.org/10.3899/jrheum.170486
Open Access
Safety and Efficacy of Tofacitinib, an Oral Janus Kinase Inhibitor, for the Treatment of Rheumatoid Arthritis in Open-label, Longterm Extension Studies
Jürgen Wollenhaupt, Joel Silverfield, Eun Bong Lee, Jeffrey R. Curtis, Susan P. Wood, Koshika Soma, Chudy I. Nduaka, Birgitta Benda, David Gruben, Hiroyuki Nakamura, Yoshihiro Komuro, Samuel H. Zwillich, Lisy Wang and Richard J. Riese

The Journal of Rheumatology May 1 2014, 41 (5) 837-852; DOI: https://doi.org/10.3899/jrheum.130683

Main menu

User menu

Search

TOFACITINIB

Content

Resources

Subscribers

More